Pharmaceutical Equivalent Study of Losartan Potassium Formulation available in Karachi, Pakistan
نویسندگان
چکیده
منابع مشابه
Formulation, In-vitro Evaluations and Skin Irritation Study of Losartan Potassium Transdermal Patches
Losartan potassium is a well known orally active non-peptide angiotensin II receptor antagonist. Losartan potassium and its principle active metabolites block the vasoconstrictor and aldosterone secreting effect of angiotensin II by selectively blocking the binding of angiotensin II to AT1 receptors. The drug is reported to promote the decrease in ventricular hypertrophy, salt ...
متن کاملPatients Comprehension of Pharmaceutical Package Inserts Information in Karachi, Pakistan
Purpose: To investigate the knowledge and attitude of outpatients regarding pharmaceutical package inserts (PPIs) in Karachi, Pakistan. Methods: The study design was cross-sectional and conducted from August to December 2013. A previously validated questionnaire was adopted, modified and revalidated. Outpatients were asked to respond to the questionnaire. Results: A total of 456 patients respon...
متن کاملFormulation and Evaluation of Buccoadhesive Films of Losartan Potassium
Buccoadhesive buccal delivery systems for losartan potassium in the form of buccal films were developed and characterized for improving bioavailability. The films were formulated by solvent casting method using different bioadhesive polymers like HPMC, Eudragit RS100, Eudragit RL100 and Ethylcellulose with glycerol as plasticizer. The films were characterized on the basis of their physical char...
متن کاملMouth Dissolving Tablets of Losartan Potassium: Formulation and Evaluation
Losartan potassium is an angiotention receptor antagonist, used in the management of hypertension. The objective of the proposed research work is to prepare and evaluate the mouth dissolving/disintegrating tablets (MDTs) of losartan Potassium, which avoid the first-pass metabolism, improved the dissolution rate and enhance the bioavailability. Mouth dissolving tablets (MDTs) were prepared by di...
متن کاملformulation, in-vitro evaluations and skin irritation study of losartan potassium transdermal patches
losartan potassium is a well known orally active non-peptide angiotensin ii receptor antagonist. losartan potassium and its principle active metabolites block the vasoconstrictor and aldosterone secreting effect of angiotensin ii by selectively blocking the binding of angiotensin ii to at1 receptors. the drug is reported to promote the decrease in ventricular hypertrophy, salt and water excreti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Bioequivalence & Bioavailability
سال: 2016
ISSN: 0975-0851
DOI: 10.4172/jbb.1000310